Documented security problems with compounded semaglutide consist of dosing glitches from incorrect compounding or mislabeling, contamination with germs or other destructive substances in the course of preparing, presence of impurities or unintended elements, usage of non-pharmaceutical quality active components from unregistered suppliers, and inco